Transition to HFA Inhalers

Many popular asthma inhalers won’t be available after the end of the year. If you haven’t already, start working with your child’s allergist/immunologist now to make the transition to the new versions of these inhalers.

The United States has committed, along with most of the world, to discontinue use of chlorofluorocarbons (CFCs) because of their damaging effects on the environment. As part of that effort, the U.S. Food and Drug Administration (FDA) is requiring that manufacturers of albuterol metered dose inhalers use hydrofluoroalkane (HFA) instead of CFCs to propel the medicine out of the inhaler. CFC inhalers will no longer be sold after December 31, and the pharmaceutical industry is already decreasing their production of CFC inhalers while increasing their production of HFA inhalers.

Patients will need a new prescription to receive these medications, so make an appointment with your child’s allergist/immunologist to discuss the transition.

For over 50 years, patients have relied on their metered dose inhalers to relieve asthma symptoms – such as chest tightness or difficulty breathing. Today’s HFA inhalers are as effective as CFC inhalers and use the same medication, albuterol.

Still, many pediatric patients notice differences between the inhalers and some parents have been concerned that the new HFA inhalers may not provide the appropriate dose of medication. However, HFA inhalers deliver the same dose of medication as CFC inhalers and provide the same relief of asthma symptoms.

Much of the confusion stems from changes to how the medication feels. The force of the HFA inhaler spray is softer than the CFC inhaler and may make it easier to get the medication into your child’s lungs. The new spray also has a warmer feel, rather than the cold blast of CFC inhalers. If your child complains of a different taste, have her follow the inhaler with a pleasant-tasting cold drink.